Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

Posted on April 30, 2026
By CNBC
0 Views
1 min read

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines unless they appear on the FDA's ⁠drug shortage ⁠list.